background
novel
pandem
viru
first
identifi
mexico
april
sinc
spread
worldwid
short
period
time
although
viru
infect
gener
associ
mild
diseas
rel
low
mortal
project
mutat
specif
region
viral
genom
especi
within
receptor
bind
domain
haemagglutinin
ha
protein
could
result
virul
viru
stain
lead
sever
pathogen
method
monitor
genet
polymorph
posit
haemagglutinin
influenza
virus
outpati
mild
influenza
individu
sever
diseas
requir
hospit
season
sequencebas
genotyp
assess
viral
popul
understand
preval
mutat
result
identifi
clinic
specimen
case
analyz
tunisia
sever
outcom
interestingli
one
fatal
case
four
virus
taken
fatal
case
studi
also
mutat
found
one
mild
case
mild
case
studi
substitut
found
viru
taken
one
patient
sever
clinic
syndrom
sever
case
analyz
substitut
found
two
sever
case
sever
case
studi
conclus
specif
mutat
viral
haemagglutinin
found
fatal
sever
mild
case
virolog
clinic
epidemiolog
investig
need
ascertain
role
mutat
may
alter
virul
transmiss
pandem
influenza
virtual
slide
virtual
slide
articl
found
http
wwwdiagnosticpathologydiagnomxeu
april
novel
swinederiv
influenza
emerg
spread
rapidli
around
world
caus
world
health
organ
declar
pandem
june
sinc
first
appear
influenza
one
particular
amino
acid
substitut
aspart
acid
glycin
posit
number
within
hemagglutinin
ha
molecul
appear
sporad
countri
includ
norway
mexico
ukrain
usa
substitut
known
caus
shift
receptor
specif
mix
acid
receptor
specif
noteworthi
highli
conserv
among
avian
virus
previous
avian
virus
isol
patient
initi
phase
pandem
avian
ha
human
shown
select
increas
affin
receptor
also
substitut
present
spanish
flu
outbreak
howev
exist
transmiss
influenza
specif
virus
remain
unclear
identifi
whether
specif
virus
replic
well
swine
spread
earli
phase
pandem
whether
specif
virus
easili
transmit
nucleotid
sequenc
ha
receptor
bind
site
influenza
clinic
specimen
determin
studi
attempt
understand
relev
ha
substitut
among
influenza
caus
infect
tunisia
ha
gene
sequenc
respiratori
specimen
sever
nonsever
case
examin
addit
substitut
focus
anoth
substitut
glutam
acid
lysin
acid
mutat
locat
stalk
caviti
fusion
domain
matur
ha
molecul
might
impact
antigen
neutral
activ
influenza
nasopharyng
throat
swab
specimen
influenza
patient
receiv
directli
sentinel
primari
care
physician
particip
virolog
surveil
scheme
commun
sampl
also
receiv
commun
hospitalis
fatal
case
forward
tunisia
nation
influenza
centr
diagnost
characteris
total
specimen
influenza
patient
collect
tunisia
season
specimen
season
sampl
use
studi
taken
patient
includ
respiratori
specimen
sever
patient
hospit
sever
pneumonia
sever
acut
respiratori
syndrom
fatal
case
well
case
mild
clinic
outcom
mild
case
present
least
one
follow
influenzalik
ill
symptom
fever
least
cough
rhinorrhea
headach
abdomin
symptom
ie
diarrhea
vomit
viral
rna
extract
respiratori
sampl
oropharyng
nasopharyng
swab
use
commerci
avail
qiaamp
viral
rna
mini
kit
qiagen
per
manufactur
instruct
initi
detect
influenza
viru
amplif
matrix
protein
gene
carri
real
time
rtpcr
cdc
protocol
subtyp
influenza
posit
sampl
ha
gene
segment
influenza
virus
analyz
specif
realtim
pcr
use
influenza
viru
real
time
rtpcr
kit
shanghai
zj
biotech
co
ltd
order
identifi
chang
ha
amino
acid
divers
individu
case
genet
characteris
perform
target
haemagglutinin
ha
sequenc
analysi
andor
partial
genom
nucleotid
residu
sequenc
subset
isol
virus
analyz
amplifi
sequenc
accord
protocol
nation
influenza
centr
madrid
primer
use
rtpcr
sseqb
nest
pcr
sequenc
analyz
use
maximum
composit
likelihood
method
mega
version
softwar
packag
bootstrap
replic
nucleotid
sequenc
access
number
nucleotid
sequenc
ha
determin
studi
found
genbank
databas
indic
access
number
http
wwwncbinih
govgenomesfluswinefluhtml
ethic
aspect
studi
approv
charl
nicol
hospit
ethic
committe
pandem
year
total
respiratori
specimen
ili
come
sentinel
physician
network
posit
influenza
pdm
season
case
posit
influenza
report
occurr
amino
acid
substitut
aspart
acid
glycin
posit
ha
subunit
viral
haemagglutinin
clinic
specimen
case
analyz
tunisia
sever
outcom
interestingli
one
fatal
case
four
virus
taken
fatal
case
studi
patient
die
day
suffer
sever
respiratori
symptom
flu
autopsi
reveal
pulmonari
oedema
larg
mucosi
secret
cardiac
inflamm
tabl
also
mutat
found
one
mild
case
mild
case
studi
moreov
found
one
virus
studi
mutat
found
viru
taken
one
patient
sever
clinic
syndrom
sever
case
studi
substitut
found
two
sever
case
analysi
ha
also
show
frequent
substitut
posit
detect
tunisian
virus
studi
genet
analysi
ha
influenza
viru
show
viru
reassort
contain
gene
segment
ancestor
virus
human
swine
avian
sourc
henc
polymorph
posit
within
haemagglutinin
ha
molecul
may
remark
impact
viral
host
rang
replic
pathogen
worth
note
although
mutat
current
associ
sever
pandem
human
associ
sever
initi
propos
kiland
et
al
sinc
differ
studi
sever
countri
found
substitut
frequent
associ
patient
sever
pandem
influenza
nonsever
control
case
recent
studi
support
role
mutat
allow
viru
access
deeper
lung
tissu
hese
unusu
viral
attribut
suggest
new
viru
may
possess
virul
characterist
similar
highli
pathogen
pandem
influenza
virus
studi
use
convent
sequenc
approach
analyz
sampl
obtain
virus
substitut
ha
protein
appear
sporad
spontan
tunisia
sinc
juli
although
found
sever
case
present
studi
substitut
percentag
compar
found
itali
unit
kingdom
franc
spain
lower
publish
norway
hong
kong
differ
norwegian
chines
studi
might
due
reduc
number
sever
case
analyz
countri
tunisia
mutat
observ
circul
viru
obtain
sever
case
also
mild
case
frequenc
substitut
higher
sever
case
mild
case
although
studi
demonstr
presenc
substitut
sever
case
also
report
mild
case
therefor
number
mild
case
would
need
larger
determin
whether
mutant
virus
inde
circul
low
frequenc
also
nonsever
case
ge
polymorph
haemagglutinin
ha
gene
influenza
viru
associ
case
mild
sever
ill
differ
countri
geograph
area
mani
retrospect
analys
found
case
bear
mutat
like
associ
sever
pneumonia
admiss
intens
care
facil
death
major
studi
report
presenc
suffici
enhanc
viru
replic
lethal
mous
model
effect
rang
modest
pronounc
moreov
substitut
present
tunisian
viru
strain
sinc
pandem
season
throughout
season
group
observ
substanti
differ
wildtyp
virus
mous
ferret
model
indic
need
investig
role
virul
influenza
detect
less
frequenc
found
sever
case
patient
despit
avail
virolog
epidemiolog
clinic
inform
substitut
could
confer
sever
diseas
clinic
signific
mutat
still
unclear
studi
demonstr
polymorph
ha
protein
especi
within
receptor
bind
domain
play
critic
role
bind
prefer
pathogen
influenza
viru
studi
warrant
elucid
intrigu
relationship
substitut
sever
diseas
whether
select
mutat
caus
consequ
sever
lower
respiratori
tract
infect
still
resolv
evid
howev
emerg
like
exacerb
sever
diseas
alter
receptor
specif
distinct
cell
tropism
mutant
influenza
hallmark
danger
pathogen
emphas
import
close
monitor
evolut
virus
influenza
variant
ge
polymorph
show
increas
clinic
virul
detect
mutant
next
epidem
mandatori
better
manag
ili
individu
patient
well
surveil
purpos
especi
african
countri
particip
respiratori
sampl
collect
inform
consent
supervis
local
sanitari
author
abbrevi
ha
haemagglutinin
sa
sialic
acid
sa
sialic
acid
ili
influenzalik
ill
none
author
financi
person
conflict
interest
relat
studi
author
contribut
aem
propos
idea
analyz
interpret
data
present
paper
also
wrote
manuscript
fp
jl
particip
data
analysi
interpret
also
revis
manuscript
mtc
ic
revis
manuscript
mhk
revis
manuscript
save
final
approv
version
publish
author
read
approv
final
manuscript
